OXOGLURATE D’ORNITHINE MYLAN 5 g, powder for oral and gastroenteral solution in a single-dose sachet 10 sachets of 5.19 g
Active ingredients: Ornithine oxoglurate
Commercialized according to BDPM
Powder for oral and gastroenteral solution10 sachets of 5.19 ggastro-entérale;orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OXOGLURATE D’ORNITHINE MYLAN 5 g, poudre pour solution buvable et gastro-entérale en sachet-dose
- Pharmaceutical form
- poudre pour solution buvable et gastro-entérale
- Route of administration
- gastro-entérale;orale
- Presentation description
- 10 sachet(s)-dose(s) papier aluminium polyéthylène de 5,19 g
- Marketing authorisation holder
- MYLAN SAS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Oct 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64349947CIP73750753CIP133400937507530Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXOGLURATE D'ORNITHINEpoudre | 5 g · un sachet-dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.